https://newsroom.astellas.com/ https://newsroom.astellas.com/2026-10-02-New-Preliminary-Real-World-VEOZAH-fezolinetant-Data-Highlights-Improvements-in-Menopause-Related-Symptoms-and-Sleep-Outcomes Statistically significant improvements in bothersome VMS as well as sleep quality were observed at week 12, and also seen at weeks 4 and 8, among women treated with fezolinetant1 First real-world... Fri, 02 Oct 2026 08:00:00 -0400 https://newsroom.astellas.com/2026-10-02-New-Preliminary-Real-World-VEOZAH-fezolinetant-Data-Highlights-Improvements-in-Menopause-Related-Symptoms-and-Sleep-Outcomes https://newsroom.astellas.com/2026-07-09-Astellas-to-Spotlight-New-Research-for-Geographic-Atrophy-at-ASRS-2026-Annual-Meeting Late-breaking oral presentation highlights early signals of potential visual improvement and patient-reported outcomes of investigational ASP7317 in patients with advanced geographic atrophy (GA)... Thu, 09 Jul 2026 08:00:00 -0400 https://newsroom.astellas.com/2026-07-09-Astellas-to-Spotlight-New-Research-for-Geographic-Atrophy-at-ASRS-2026-Annual-Meeting https://newsroom.astellas.com/2026-04-30-Astellas-to-Highlight-New-Findings-for-Geographic-Atrophy-at-ARVO-2026-Annual-Meeting Oral presentation highlights early progress of investigational ASP7317 in the treatment of advanced geographic atrophy Encore oral presentation features long-term outcomes for IZERVAY®... Thu, 30 Apr 2026 09:00:00 -0400 https://newsroom.astellas.com/2026-04-30-Astellas-to-Highlight-New-Findings-for-Geographic-Atrophy-at-ARVO-2026-Annual-Meeting https://newsroom.astellas.com/2026-01-08-VYLOY-TM-zolbetuximab-Plus-Chemotherapy-Associated-with-Enhanced-Survival-Outcomes-when-Common-Adverse-Events-are-Effectively-Managed,-According-to-New-Ad-Hoc-Analyses Exploratory ad hoc analyses from SPOTLIGHT and GLOW trials report quantitative differences in median progression-free survival (mPFS) and median overall survival (mOS) for patients treated with... Thu, 08 Jan 2026 10:30:00 -0500 https://newsroom.astellas.com/2026-01-08-VYLOY-TM-zolbetuximab-Plus-Chemotherapy-Associated-with-Enhanced-Survival-Outcomes-when-Common-Adverse-Events-are-Effectively-Managed,-According-to-New-Ad-Hoc-Analyses https://newsroom.astellas.com/2025-10-23-Astellas-and-the-Internets-Favorite-Grandma,-Barbara-Babs-Costello,-Partner-to-Encourage-Others-to-Get-Ahead-of-Geographic-Atrophy-GA Babs is sharing her family’s history with progressive retinal disease GA, the advanced form of dry age-related macular degeneration (AMD), is a serious condition that may lead to irreversible... Thu, 23 Oct 2025 08:00:00 -0400 https://newsroom.astellas.com/2025-10-23-Astellas-and-the-Internets-Favorite-Grandma,-Barbara-Babs-Costello,-Partner-to-Encourage-Others-to-Get-Ahead-of-Geographic-Atrophy-GA